Axxess Pharma, Inc. Announces New TapouT Product Order From Victory Brands Following Sell-Out Of Initial Order

TORONTO, ON--(Marketwired - January 21, 2014) - Axxess Pharma Inc. (PINKSHEETS: AXXE) a specialty pharmaceutical and nutritional supplements company is pleased to announce they have received a new order for TapouT-branded all-natural pain relief products from Victory Brands, Inc. The new order was placed through Axxess Pharma’s wholly-owned subsidiary; AllStar Health Brands Inc. Victory Brands is Canada’s leading distributors of Health, Fitness and Nutrition products.

Based on the success of the initial sales effort, AllStar and Victory are preparing a more comprehensive marketing campaign aimed at expansion into larger retail outlets.

Ian Bell, President of Victory Brands, stated: “After quickly selling out the initial order, our customers have placed new orders with us for the TapouT line. This bodes well for the growth prospects of this brand across Canada.”

Daniel Bagi, President of Axxess stated, “We are extremely delighted with this new order. We are working hard to drive further growth and reach more customers through a ramp-up in marketing of our TapouT line.”

In addition to the mass retail stores, the TapouT product line is available online at http://www.supplementsource.ca/ and http://www.vitamart.ca/, two of Canada’s leading online retail outlets.

About Axxess Pharma Inc.:
Axxess Pharma Inc. is a Nevada Corporation operating through its wholly-owned Canadian Subsidiary: Axxess Pharma Canada Inc., headquartered in Toronto. Axxess is a specialty Health Care Products Company dedicated to improving health and quality of life by offering select medicines, nutritional supplements and over the counter remedies all across the Americas. Axxess’s goal is to bring additional products to the market and provide new, innovative options for better health spanning areas such as high cholesterol, blood pressure, acute pain, -- to optimal health management through improved nutritional supplements.

For more information, please visit www.axxesspharmainc.com, or contact Investor Relations at (973) 351-3868.

Safe Harbor Statement

Statements about the Company’s future expectations and all other statements in this press release other than historical facts, are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby.

The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management, as well as assumptions made by any information currently available to the Company or its management. When used in this document, the words “anticipate,” “estimate,” “expect,” “intend,” “plans,” “projects,” and similar expressions, as they relate to the Company or its management, are intended to identify forward-looking statements. Such statements reflect the current view of the Company regarding future events and are subject to certain risks, uncertainties and assumptions, including the risks and uncertainties noted. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove to be incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected, intended or projected. In each instance, forward-looking information should be considered in light of the accompanying meaningful cautionary statements herein. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, the impact of competitive services and pricing and general economic risks and uncertainties.